Jiangsu Yahong Meditech Co., Ltd. (SHA:688176)

China flag China · Delayed Price · Currency is CNY
17.27
-0.39 (-2.21%)
Mar 10, 2026, 2:04 PM CST
106.33%
Market Cap 9.93B
Revenue (ttm) 277.12M
Net Income (ttm) -419.34M
Shares Out 562.50M
EPS (ttm) -0.75
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 34,743,702
Average Volume 16,363,429
Open 17.34
Previous Close 17.66
Day's Range 17.07 - 18.11
52-Week Range 6.80 - 18.07
Beta 0.65
RSI 79.96
Earnings Date Apr 18, 2026

About Jiangsu Yahong Meditech

Jiangsu Yahong Meditech Co., Ltd., a pharmaceutical company, focuses on urogenital tumors and women's health in China and internationally. It develops APL-1702, a photodynamic therapy product for the treatment of high-grade squamous intraepithelial lesions of the cervix, as well as for HPV virus clearance indication; APL-1706 and APLD-2304 for non-muscle invasive bladder cancer (NMIBC) diagnosis and surgery indication; APL-1202, an oral reversible MetAP2 inhibitor for untreated intermediate-risk NMIBC and neoadjuvant therapy before muscle-invas... [Read more]

Sector Healthcare
Founded 2010
Employees 399
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688176
Full Company Profile

Financial Performance

In 2025, Jiangsu Yahong Meditech's revenue was 277.12 million, an increase of 37.49% compared to the previous year's 201.56 million. Losses were -419.34 million, 9.19% more than in 2024.

Financial Statements

News

There is no news available yet.